<DOC>
	<DOCNO>NCT01524432</DOCNO>
	<brief_summary>This study hygienic sock antifungal agent-loaded microcapsules subject interdigital type tinea pedis ( athlete 's foot toe ) . This 6 week study 2 week treatment period 4 week follow-up evaluation .</brief_summary>
	<brief_title>Hygienic Socks With Antifungal Agent-loaded Microcapsules Patients With Tinea Pedis</brief_title>
	<detailed_description>Tinea pedis ( Athlete 's Foot ) common skin disease affect large number population . The development hygienic sock microencapsulation technology great potential provide convenient pharmacological treatment one hand , good moisture management reduce microbial overgrowth hand patient tinea pedis . The sock , therefore , reduce effect skin disease quality life .</detailed_description>
	<mesh_term>Tinea</mesh_term>
	<mesh_term>Tinea Pedis</mesh_term>
	<mesh_term>Antifungal Agents</mesh_term>
	<mesh_term>Miconazole</mesh_term>
	<criteria>Be least 18 year age either sex . Subjects must clinical evidence interdigital tinea pedis one foot characterize : ( ) moderate erythema , ( ii ) scaling ( iii ) mild pruritis . Have microscopic evidence ( positive KOH ) presence fungi . Evaluable subject must positive KOH fungal culture positive dermatophyte skin scraping take Baseline Visit . Subjects positive KOH may enter study pending result fungal culture Be willing able give inform consent/assent parent/guardian , applicable . Be willing able use assign study medication direct commit followup visit duration study . Be good health free disease physical condition might , Investigator 's opinion , expose subject unacceptable risk study participation . Females must nonpregnant , nonlactating intend become pregnant course study . Is pregnant , nurse plan pregnancy study . Has use topical antifungal topical corticosteroid foot within 4 week prior start study . Has receive systemic antifungal therapy within 4 week prior start study medication . Has use systemic antibacterial systemic corticosteroid within 4 week prior start study . Systemic corticosteroid include intranasal , inhale , ophthalmic corticosteroid use management allergy , pulmonary disorder condition . Has history uncontrolled diabetes mellitus immunocompromised ( due disease , e.g. , HIV , medication ) . Has concurrent tinea infection e.g . Tinea Versicolor , Tinea Cruris , Moccasintype Tinea Pedis , etc . ( opinion Investigator ) . Onychomycosis , involve â‰¥ 20 % area either great toenail involvement five toenail total . Has skin disease might interfere evaluation tinea pedis . Is currently enrol investigational drug device study . Has receive investigational drug treatment investigational device within 30 day prior enter study . Is unreliable , include subject history drug alcohol abuse . Has know hypersensitivity component study medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Clotrimazole</keyword>
	<keyword>Microcapsules</keyword>
</DOC>